“…Recombinant MAP vaccines should have various merits over killed or attenuated vaccines in terms of antigen production and human safety. The most commonly evaluated recombinant proteins have been Hsp 70 (Koets et al, 2006), antigen 85, 74F, SOD, 35 kDa (Chen et al, 2008; Kathaperumal et al, 2008; Park et al, 2008), mpt (Heinzmann et al, 2008), 95 kDa (Bull et al, 2007), P22 (Rigden et al, 2006), 65 kDa (Velaz-Faircloth et al, 1999), and 16.8 kDa (Kadam et al, 2009). Many of the recombinant vaccines were reported to induce strong cellular as well as antibody mediated immune responses (Rigden et al, 2006; Kathaperumal et al, 2008; Roupie et al, 2008).…”